Usana Health Sciences
USNA
169 hedge funds and large institutions have $655M invested in Usana Health Sciences in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 32 closing their positions.
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
0.24% less ownership
Funds ownership: 52.84% → 52.6% (-0.24%)
6% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 32
3% less funds holding
Funds holding: 175 → 169 (-6)
27% less capital invested
Capital invested by funds: $898M → $655M (-$243M)
94% less call options, than puts
Call options by funds: $805K | Put options by funds: $13.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$4.62M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.85M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.47M |
| 4 |
Morgan Stanley
New York
|
+$3.23M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
-$8.39M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$7.08M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$5.95M |
| 4 |
BlackRock
New York
|
-$4.68M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.65M |
USNA Hedge Fund Activity: Q1 2020 in Review
169 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2020, worth a combined $655M — down 27% from $898M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of USNA and 30 opened new positions — a net loss of 2 holders — while 51 trimmed existing stakes and 52 added.
The largest buyer was Granite Investment Partners, opening a new position worth an estimated $4.62M. The largest seller was Nuveen, cutting an estimated $8.39M.
- 169 institutional investors held Usana Health Sciences (USNA) as of Q1 2020, down from 175 in Q4 2019.
- Funds reported $655M of Usana Health Sciences stock for Q1 2020, down 27% quarter-over-quarter.
- 30 funds opened new Usana Health Sciences positions in Q1 2020 and 32 closed out, a net change of -2 holders.
- The largest Usana Health Sciences buyer in Q1 2020 was Granite Investment Partners, an estimated $4.62M added.
- The largest Usana Health Sciences seller in Q1 2020 was Nuveen, an estimated $8.39M sold.
Based on aggregated 13F filings for Q1 2020.